Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2010
03/31/2010CN101684118A Use of tricyclic compounds as glycine transport inhibitors
03/31/2010CN101684101A Piperazinone substituted tetracycline derivatives
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687639 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
03/30/2010US7687638 C-(3-Methyl-5-phenyl-3H-benzoimidazol-4-yl)-methylamine; diabetes, fasting plasma glucose (IFG), metabolic acidosis, ketosis, appetite regulation, obesity, immunosuppressants or cytokine release regulation, autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and arthritis
03/30/2010US7687629 Process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate
03/30/2010US7687628 Method of preparing 4-amino-1H-imidazo(4,5-c)quinolines and acid addition salts thereof
03/30/2010US7687625 Antidiabetic agents; obesity; controlling appetite
03/30/2010US7687620 [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
03/30/2010US7687515 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
03/30/2010US7687514 Benzimidazole derivatives
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687086 Method for obtaining taxanes
03/30/2010CA2360685C Methods for restoring and/or enhancing accommodation in pseudo phakia
03/25/2010WO2010033980A2 4-azaindole bisphosphonates
03/25/2010WO2010033978A2 IMIDAZO[1,2-α ]PYRIDINYL BISPHOSPHONATES
03/25/2010WO2010033941A1 Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
03/25/2010WO2010033801A1 Morphinan compounds
03/25/2010WO2010033495A2 Functionally selective azanitrile alpha2c adrenoreceptor agonists
03/25/2010WO2010033451A2 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators
03/25/2010WO2010033393A1 Substituted 3 -amin0- 1-0x0 or thioxo-i, 2,5,6,7, 8-hexahydr0-2, 7-naphthyridine-4-carb0nitriles as selective alpha 2b antagonists
03/25/2010WO2010032886A1 Agricultural composition for controlling or preventing plant disease caused by plant pathogenic bacterium
03/25/2010WO2010032881A1 Plant disease control agent
03/25/2010WO2010032200A1 Amide compounds useful in therapy
03/25/2010WO2010032195A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
03/25/2010WO2010031791A1 New compounds ii
03/25/2010WO2010031789A1 New compounds i
03/25/2010WO2010031184A1 Azaindole derivatives as crth2 receptor antagonists
03/25/2010WO2010031183A1 Indole derivatives as crth2 receptor antagonists
03/25/2010WO2010031182A1 Indole derivatives as crth2 receptor antagonists
03/25/2010WO2010008777A3 Fused azabicyclic pyridines
03/25/2010US20100076194 Substituted 3-amino-1-oxo or thioxo-1,2,5,6,7,8-hexahydro-2,7-naphthyridine-4-carbonitriles are selective alpha 2b antagonists
03/25/2010US20100076193 process for the preparation of gemifloxacin
03/25/2010US20100076191 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
03/25/2010US20100076190 Method for synthesis of nitroxyl radical
03/25/2010US20100076014 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100076011 Enantiomer-Pure Hexahydro-Pyrrolocyclopenta-Pyridine Derivatives
03/25/2010US20100076003 5-oxazolidin-2-one substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful as orl-1 receptor modulators
03/25/2010US20100075998 Tricyclic indoles and (4,5-dihydro) indoles
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075980 Phenylacetamides being FLT3 Inhibitors
03/25/2010US20100075973 Polo-like kinase inhibitors
03/25/2010US20100075965 Pi3 kinase inhibitors and methods of their use
03/25/2010US20100075958 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/25/2010US20100075927 Chemotherapeutic conjugates and methods of use
03/25/2010DE102008047314A1 Radioaktiv-markierte Cyclopropan-Derivate DAT-affiner Tropane Radioactively labeled cyclopropane derivatives DAT affinity Tropanes
03/25/2010CA2738026A1 Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
03/25/2010CA2737811A1 Morphinan compounds
03/25/2010CA2737740A1 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators
03/25/2010CA2737604A1 Substituted 3-amin0-1-0x0 or thioxo-1,2,5,6,7,8-hexahydr0-2,7-naphthyridine-4-carb0nitriles as selective alpha 2b antagonists
03/25/2010CA2737527A1 New compounds i
03/25/2010CA2737483A1 Indole derivatives as crth2 receptor antagonists
03/25/2010CA2737460A1 Indole derivatives as crth2 receptor antagonists
03/25/2010CA2736571A1 Azaindole derivatives as crth2 receptor antagonists
03/25/2010CA2735931A1 Amide compounds useful in therapy
03/24/2010EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2166009A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
03/24/2010EP2166008A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2165708A2 New pyrazole derivatives as transforming growth factor (tgf) inhibitors
03/24/2010EP2165707A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2164850A2 N-substituted azaindoles and methods of use
03/24/2010EP2164849A2 Pyridopyrazine derivatives, process of manufacturing and uses thereof
03/24/2010EP2164847A1 3-aza-bicyclo[3.3.0]octane compounds
03/24/2010EP2164828A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
03/24/2010EP2164328A1 Therapeutic pyrazoloquinoline urea derivatives
03/24/2010EP2046791B1 Urea derivatives of tropane, their preparation and their therapeutic application
03/24/2010EP1560821B1 Antibacterial agents
03/24/2010CN101679431A A method for the preparation of an enantiomer of a tetracyclic benzazepine
03/24/2010CN101679430A 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-i receptor for the treatment of anxiety and depression
03/24/2010CN101679429A 5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer
03/24/2010CN101679428A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
03/24/2010CN101679427A Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
03/24/2010CN101679426A 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidaz0[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
03/24/2010CN101679425A 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives
03/24/2010CN101679424A 2, 6-naphthyridine derivatives as protein kinase modulators
03/24/2010CN101679423A Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
03/24/2010CN101679422A Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
03/24/2010CN101679421A New imidazo[ 4,5-b]pyridine-7-carboxamides 704
03/24/2010CN101679420A A method for the preparation of an enantiomerically pure benzazepine
03/24/2010CN101679419A Pure paliperidone and processes for preparing thereof
03/24/2010CN101679418A [2, 6] naphthyridines useful as protein kinase inhibitors
03/24/2010CN101679417A New 4,8-diphenyl-polyazanaphthalene derivatives
03/24/2010CN101679416A Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3, 4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceu
03/24/2010CN101679415A oxazolidinone antibiotics
03/24/2010CN101679414A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
03/24/2010CN101679413A New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
03/24/2010CN101679412A Purinones and 1h-imidazopyridinones as PKC-theta inhibitors
03/24/2010CN101679411A mapk/erk kinase inhibitors
03/24/2010CN101679410A 2-[(2-substituted)-ind0lizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents
03/24/2010CN101679409A New compounds
03/24/2010CN101679408A Bicyclic heterocyclic compounds as FGFR inhibitors
03/24/2010CN101679405A 2-aminopyridine analogs as glucokinase activators
03/24/2010CN101679399A Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
03/24/2010CN101679381A Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
03/24/2010CN101679357A Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/24/2010CN101679306A Heteroarylamide pyrimidone derivatives
03/24/2010CN101679299A Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
03/24/2010CN101679272A Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands
03/24/2010CN101679270A dihydroquinone and dihydronaphthridine inhibitors of jnk
03/24/2010CN101679260A 4,4-disubstituted piperidine derivatives
1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 646